sci-news.jpeg

sci-news

shimin.jpeg

shimin

eppharmaline.gif

eppharmaline

findat.jpeg

findat

yakuzemi.png

yakuzemi

new-lifescience.gif

new-lifescience

biopharmaceuticals.gif

biopharmaceuticals

jssx36.png

jssx36

convention.jpeg

convention

jshp2022-thk.png

jshp2022-thk

jasdi24.png

jasdi24

General information

Announcements(0)

Greetings from Chair

Overview

Registration

General information 2

Abstract Submission (Oral/Poster Presentation)

Program

Sessions

Search presentations

pharm142_en.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

A password that applicants have been notified of is required to view abstracts.<br>If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.<br>We will reply after confirming that you were a participant.<br>Thank you for your understanding.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Profile management

Bookmark

Download PDF for print

Timetable

AMED iD3 Booster and Development of a Next-generation Drug Discovery AI through Industry-academia Collaboration (DAIIA)

The tide of digital transformation is bringing about a transformation in the structure and concept of healthcare. Smartphones and PCs have become a part of our daily lives, and we live in an age where digital natives, who can use social networking services as if they were breathing, and can take in information from around the world without any time lag, are supporting society. On the other hand, as exposed by the COVID-19 pandemic, we should admit that our country's response to the digital revolution is far from advanced. What about the world of pharmaceutical Sciences? Digital technology is permeating every aspect of drug discovery and clinical practice, but how far has it progressed and how will it progress in the future? The Board of Directors of the Pharmaceutical Society of Japan (PSJ) would like to share its vision with our members. In this symposium, we invite leading figures who are promoting digital innovation at the forefront of drug discovery, medical care, and administration to give lectures on the actual status of digital technology in pharmaceutical research in a wide range of areas, and take this as an opportunity to start discussions with you on the future vision of pharmaceutical science.

Current status and prospects of digital healthcare

The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Presentation Information

[OS01-1]AMED iD3 Booster and Development of a Next-generation Drug Discovery AI through Industry-academia Collaboration (DAIIA)

Password required to view